Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions

Greco, A.V.; Mingrone, G.; Mari, A.; Capristo, E.; Manco, M.; Gasbarrini, G.
December 2002
Gut;Dec2002, Vol. 51 Issue 6, p870
Academic Journal
Aims: Human liver cirrhosis is commonly associated with increased fasting and glucose induced insulin concentrations. However, whether the hyperinsulinaemia is a consequence of increased pancreatic insulin secretion, decreased hepatic insulin removal, or impaired feedback regulation of insulin secretion is still doubtful. To investigate these issues, insulin secretion-during 24 hours of standardised living conditions-insulin sensitivity, and hepatic insulin extraction were assessed in cirrhotic patients compared with matched healthy subjects. Patients: Nine Child's disease grade B cirrhotic patients and seven healthy volunteers, participated in the study. The subjects were studied on two separate days, one for the assessment of insulin secretion during a stondardised 24 hour life period (calorimetric chamber), and one for the determination of insulin sensitivity. Methods: Insulin secretion rates were reconstructed from plasma C peptide concentrations by deconvolution, and indices of β cell function were derived using a mathematical model describing the functional dependence of insulin secretion on plasma glucose concentrations. Insulin sensitivity was determined using the euglycaemic hyperinsulinaemic clamp technique. Results: Cirrhotic patients showed a marked hypersecretory response, both in absolute terms (mean (SEM) 295 (53) versus 138 (11) nmol/m², p<0.02), and in relation to glucose (175 (26) versus 57 (5) pmol/min/m², p<0.02). In particular, the I@ cell dose-response function was shifted upward compared with controls. The sensitivity of insulin secretion to the rate of glucose change was also increased. Insulin sensitivity, markedly reduced in cirrhosis (157 (10)versus 296 (30) ml/min/m², p<0.002), was strongly inversely correlated (r=0.89, p<0.002) in these patients with insulin secretion at 5 mM glucose. Insulin clearance and hepatic insulin extraction were not reduced. A frank hypermetabolism with increased lipid oxidation was...


Related Articles

  • Platelet count/spleen diameter ratio predicted the presence of esophageal varices in liver cirrhosis.  // ACP Journal Club;May/Jun2004, Vol. 140 Issue 3, pA-16 

    Presents a correction to the article "Platelet Count/Spleen Diameter Ratio Predicted the Presence of Esophageal Varices in Liver Cirrhosis," previously published in the March-April 2004 issue of the "ACP Journal Club."

  • Plasma methionine enkephalin concentration and prognosis in primary biliary cirrhosis. Thornton, J.R.; Losowsky, M.S. // BMJ: British Medical Journal (International Edition);11/12/88, Vol. 297 Issue 6658, p1241 

    Examines the importance of methionine enkephalin concentration for the diagnosis of patients with primary biliary cirrhosis. Severity of the disease; Evaluation of the clinical course of the disease; Diagnosis of the disease.

  • Desmopressin and bleeding time in patients with cirrhosis. Burroughs, Andrew K.; Matthews, Katherine; Qadiri, Mohammed; Thomas, Nigel; Kernoff, Peter; Tuddenham, Edward; McIntyre, Neil // British Medical Journal (Clinical Research Edition);11/16/1985, Vol. 291 Issue 6506, p1377 

    Examines desmopressin and bleeding time in patients with cirrhosis. Effects of desmopressin acetate on shortening the bleeding time; Ability of concomitant administration of tranexamic acid in blocking increased fibrinolysis; Usability of desmopressin in correcting defects in hemostasis in...

  • Primary biliary cirrhosis: an epidemiological study. Triger, David R. // British Medical Journal;9/20/1980, Vol. 281 Issue 6243, p772 

    Presents an epidemiological study on primary biliary cirrhosis. Risk factors; Signs and symptoms of the disease; Influence of water supply sanitation on the prevention of the disease.

  • Cyclosporin A nephrotoxicity related to changes in haemoglobin concentration. Robson, Simon; Neuberger, James; Alexander, Graeme; Williams, Roger // British Medical Journal (Clinical Research Edition);5/12/1984, Vol. 288 Issue 6428, p1417 

    Describes the effects of cyclosporin A on primary biliary cirrhosis among aged females. Development of nephrotoxicity; Correlation of nephrotoxicity to decrease in hemoglobin concentration; Pharmacokinetics of the drug.

  • Synchronous focal liver lesions in a patient with liver cirrhosis: commonplaces may be misleading. Ghittoni, Giorgia; Caturelli, Eugenio; Rossi, Sandro // Gut;Aug2010, Vol. 59 Issue 8, p1155 

    A letter to the editor is presented in response to the article "Synchronous focal liver lesions in a patient with liver cirrhosis: commonplaces may be misleading," published in a previous issue.

  • Spironolactone-Induced Hyperchloremic Acidosis in Cirrhosis. Gabow, Patricia A.; Moore, Scott; Schrier, Robert W. // Annals of Internal Medicine;Mar79, Vol. 90 Issue 3, p338 

    Presents information on a study which determined the role of spironolactone therapy on the development of metabolic acidosis in patients with alcoholic cirrhosis. Methodology; Results; Discussion.

  • Long-term fibrate treatment for PBC. Nakamuta, Makoto; Enjoji, Munechika; Kotoh, Kazuhiro; Shimohashi, Naoya; Tanabe, Yuichi // Journal of Gastroenterology;May2005, Vol. 40 Issue 5, p546 

    Presents a letter to the editor about long-term fibrate treatment for primary biliary cirrhosis.

  • Effect of cirrhosis of the liver on the pharmacokinetics of chlormethiazole. Pentikainen, P.J.; Neuvonen, P.J.; Tarpila, S.; Syvalahti, E. // British Medical Journal;9/23/1978, Vol. 2 Issue 6141, p861 

    Examines the effect of cirrhosis of the liver on the pharmacokinetics of chlormethiazole. Increase on the systemic bioavailability of oral chlormethiazole; Discussion on the proper dosage of chlormethiazole; Importance of hepatic blood flow for first-pass metabolism.


Read the Article


Sign out of this library

Other Topics